Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair

Greg Stratmann1, Isobel A Russell, Scott H Merrick

  • 1Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, California 94143, USA. gstratmann@anesthesia.ucsf.edu

Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...